Cite
HARVARD Citation
Phillips, E. et al. (2019). Toxicity and efficacy of alemtuzumab combined with CHOP for aggressive T-cell lymphoma: a phase 1 dose-escalation trial. Leukemia & lymphoma. 60 (9), pp. 2291-2294. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Phillips, E. et al. (2019). Toxicity and efficacy of alemtuzumab combined with CHOP for aggressive T-cell lymphoma: a phase 1 dose-escalation trial. Leukemia & lymphoma. 60 (9), pp. 2291-2294. [Online].